Wang Shanxi, Li Shuzhen, Xie Xing, Xie Juying
College of Rehabilitation, Xiangnan University, Chenzhou 423000, China.
Affiliated Hospital of Xiangnan University, Chenzhou 423000, China.
Evid Based Complement Alternat Med. 2020 Aug 5;2020:5074824. doi: 10.1155/2020/5074824. eCollection 2020.
Osteoporosis (OP) is a well-established age-related disease, pathologically characterized by bone microarchitectural deterioration, increased fragility, and low BMD. Primary osteoporosis (POP) is the most common type of OP.
Publications pertaining to the effectiveness of kinesitherapy on BMD in POP from PubMed, SCI, Cochrane Library, Embase, VIP, CNKI, and Wanfang Database were retrieved from their inception to October 2019.
A total of 21 studies with 1840 participants were included. The results of the meta-analysis revealed that kinesitherapy plus antiosteoporosis medications had a positive effect on lumbar spine BMD when the duration of intervention was 6 months (MD = 0.11 g/cm; 95% CI: 0.06-0.15; < 0.0001) or >6 months (MD = 0.04 g/cm; 95% CI: 0.02-0.06; < 0.0001) compared with antiosteoporosis medications alone. Additional kinesitherapy plus antiosteoporosis medications were associated with improved femoral neck BMD compared with antiosteoporosis medications alone (MD = 0.09 g/cm; 95% CI: 0.03-0.16; =0.004).
Kinesitherapy plus antiosteoporosis medications significantly improved lumbar spine and femoral neck BMD in the current low-quality evidence. Additional high-quality evidence is required to confirm the effect of kinesitherapy on BMD in patients with POP.
骨质疏松症(OP)是一种公认的与年龄相关的疾病,其病理特征为骨微结构恶化、脆性增加和骨密度(BMD)降低。原发性骨质疏松症(POP)是最常见的OP类型。
从PubMed、SCI、Cochrane图书馆、Embase、维普、中国知网和万方数据库中检索自建库至2019年10月有关运动疗法对POP患者BMD有效性的文献。
共纳入21项研究,1840名参与者。荟萃分析结果显示,与单纯使用抗骨质疏松药物相比,当干预持续时间为6个月(MD = 0.11 g/cm;95%CI:0.06 - 0.15;P < 0.0001)或>6个月(MD = 0.04 g/cm;95%CI:0.02 - 0.06;P < 0.0001)时,运动疗法联合抗骨质疏松药物对腰椎BMD有积极影响。与单纯使用抗骨质疏松药物相比,额外的运动疗法联合抗骨质疏松药物与改善股骨颈BMD相关(MD = 0.09 g/cm;95%CI:0.03 - 0.16;P = 0.004)。
在当前低质量证据下,运动疗法联合抗骨质疏松药物可显著改善腰椎和股骨颈BMD。需要更多高质量证据来证实运动疗法对POP患者BMD的影响。